BioSpace News Archive

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the year ended December 31, 2022.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the fourth quarter and full year ended on December 31, 2022.

ContraFect Corporation(Nasdaq: CFRX) today announces business updates and financial results for the fourth quarter and full year ended December 31, 2022.

Centene Corporation announced that it will release its 2023 first quarter financial results at approximately 6 a.m. on Tuesday, April 25, 2023, and will host a conference call afterwards at approximately 8:30 a.m. to review the results.

Telesis Bio Inc. announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to enable DNA amplification and scale-up.

Prothena Corporation plc (NASDAQ:PRTA) today announced new preclinical data from its PRX012 program, a potential best-in-class anti-amyloid beta (Aβ) product candidate in development for the treatment of Alzheimer’s disease, at the 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD) in Gothenburg, Sweden.

JelloX Biotech Inc., a Taiwan-based startup focused on cancer pathology, announced involvement with two new research breakthroughs that demonstrate expanded potential for its specialized technology combining 3D imaging and AI.

Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today announced the development plans of a first-in-class novel peptide drug candidate against GPC3.

Scribe Therapeutics Inc. announced it will participate in the upcoming Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days, taking place from Monday, April 3 to Tuesday, April 4, 2023 in New York, NY. Scribe’s CEO Benjamin Oakes, PhD, is scheduled to join the private company panel at 1:00 PM EST on Monday, April 3 at the Lotte New York Palace.

RAYUS Radiology has bolstered its line of high-end imaging technology solutions with the installation of the new NAEOTOM Alpha® CT scanner from Siemens Healthineers at its Palm Beach Gardens, Florida location – the first CT scanner of its kind serving patients in South Florida.